Inspire Medical Systems, Inc. Repayments of Long-Term Debt
Inspire Medical Systems, Inc. (INSP) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-02-10
- Inspire Medical Systems, Inc. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- Inspire Medical Systems, Inc. repayments of long-term debt for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- Inspire Medical Systems, Inc. repayments of long-term debt for the quarter ending 2022-09-30 was $21.44M.
- Inspire Medical Systems, Inc. repayments of long-term debt for fiscal 2024 was $0.00.
- Inspire Medical Systems, Inc. repayments of long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Inspire Medical Systems, Inc. repayments of long-term debt for fiscal 2022 was $24.50M.
- Inspire Medical Systems, Inc. repayments of long-term debt for fiscal 2021 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-10 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $0.00 10-K · filed 2025-02-10 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $21.44M derived: sum of 2 quarters · filed 2025-02-10 | $24.50M 10-K · filed 2025-02-10 | |
| 2022-09-30 | $21.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $24.50M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.06M 10-Q · filed 2023-08-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $0.00 10-K · filed 2024-02-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |